Greenwich LifeSciences, Inc.
GLSI
$16.80
$0.422.56%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.88M | 10.51M | 6.18M | 3.81M | 3.13M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.88M | 10.51M | 6.18M | 3.81M | 3.13M |
|
|
|||||
| Total Current Assets | 8.88M | 10.51M | 6.18M | 3.81M | 3.13M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 8.88M | 10.51M | 6.18M | 3.81M | 3.13M |
|
|
|||||
| Total Accounts Payable | 4.81M | 4.29M | 4.65M | 888.00K | 1.08M |
| Total Accrued Expenses | 951.70K | 947.00K | 1.17M | 734.00K | 610.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.76M | 5.24M | 5.82M | 1.62M | 1.69M |
|
|
|||||
| Total Current Liabilities | 5.76M | 5.24M | 5.82M | 1.62M | 1.69M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.76M | 5.24M | 5.82M | 1.62M | 1.69M |
|
|
|||||
| Common Stock & APIC | 99.86M | 98.06M | 87.49M | 79.77M | 74.88M |
| Retained Earnings | -96.74M | -92.79M | -87.14M | -77.59M | -73.44M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.12M | 5.27M | 353.20K | 2.19M | 1.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.12M | 5.27M | 353.20K | 2.19M | 1.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.12M | 5.27M | 353.20K | 2.19M | 1.44M |
|
|
|||||